Blackstone Valley Community Health Care: drugs
Schedule G of this filing lists 54 drugs, with an amount and a number of claims for each, as filed. Every amount links to its page of the filing.
The schedule's total is printed as “Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement”. The filings describe the amounts in more than one way. Methods says more.
- 54drugs listed
- $3,195,260.14 (Schedule G, printed total, page 8 of the filing PDF)Total as filed
- 39,738 (Schedule G, printed claims total, page 8 of the filing PDF)Claims total as filed
- 6rows show “fewer than 6” for claims. What this means
All 54 drug rows
| Line | Drug | Amount as filed | Claims as filed |
|---|---|---|---|
| 1 | Ozempic169418113, 169413013, 169477212 | 508,090.64 (Schedule G, line 1, page 8 of the filing PDF) | 583 |
| 2 | Jardiance597015230, 597015290, 5970153301 more597015390 | 441,945.42 (Schedule G, line 2, page 8 of the filing PDF) | 401 |
| 3 | Trulicity00002-1434-80, 2143380, 22236801 more2318280 | 208,081.14 (Schedule G, line 3, page 8 of the filing PDF) | 198 |
| 4 | Lantus Solostar 100 units/mL SOPN88222033, 88221905 | 173,895.41 (Schedule G, line 4, page 8 of the filing PDF) | 560 |
| 5 | Farxiga tabs310621030, 310621090, 3106205301 more310620590 | 173,518.31 (Schedule G, line 5, page 8 of the filing PDF) | 206 |
| 6 | Januvia tablets00006027731, 6027754, 000060221313 more6022154, 6011231, 6011254 | 129,158.56 (Schedule G, line 6, page 8 of the filing PDF) | 163 |
| 7 | Eliquis tabs3089321, 3089421 | 97,349.06 (Schedule G, line 7, page 8 of the filing PDF) | 127 |
| 8 | Basaglar KwikPen SOPN00002-7715-59Listed by the FDA as Basaglar KwikPeninsulin glargine100 IU/mLinjection, solutionEli Lilly and Company | 49,427.30 (Schedule G, line 8, page 8 of the filing PDF) | 151 |
| 9 | Mounjaro2147180, 2150680,2148480 | 44,721.96 (Schedule G, line 9, page 8 of the filing PDF) | 43 |
| 10 | Vivitrol 380 mg SUSR65757030001Listed by the FDA as VivitrolnaltrexonekitAlkermes, Inc. | 43,382.12 (Schedule G, line 10, page 8 of the filing PDF) | 29 |
| 11 | Xarelto 20 mg tabs50458057990Listed by the FDA as Xareltorivaroxaban20 mgtablet, film coatedJanssen Pharmaceuticals, Inc. | 39,623.52 (Schedule G, line 11, page 8 of the filing PDF) | 42 |
| 12 | Viagra tabs69422030, 58151042893, 69421030 | 37,293.10 (Schedule G, line 12, page 8 of the filing PDF) | 28 |
| 13 | Dapagliflozin Propanediol tabs66993045630, 66993045730 | 36,497.74 (Schedule G, line 13, page 8 of the filing PDF) | 206 |
| 14 | Skyrizi pen 150 mg/mL (1 mL)00074210001Listed by the FDA as Skyrizirisankizumab-rzaa150 mg/mLinjectionAbbVie Inc. | 34,645.33 (Schedule G, line 14, page 8 of the filing PDF) | fewer than 6 (the count is not shown) |
| 15 | Tradjenta 5 mg tabs597014030, 597014090 | 33,445.99 (Schedule G, line 15, page 8 of the filing PDF) | 37 |
| 16 | Invokana tabs50458014030, 50458014090, 50458014130 | 29,287.20 (Schedule G, line 16, page 8 of the filing PDF) | 22 |
| 17 | Ocrevus 300 mg/10 mL SDV50242015001Listed by the FDA as Ocrevusocrelizumab300 mg/10 mLinjectionGenentech, Inc. | 27,387.60 (Schedule G, line 17, page 8 of the filing PDF) | fewer than 6 (the count is not shown) |
| 18 | Actemra inj ACTPen50242-0143-01Listed by the FDA as Actemra ACTPentocilizumab162 mg/0.9 mLinjection, solutionGenentech, Inc. | 27,118.84 (Schedule G, line 18, page 8 of the filing PDF) | 11 |
| 19 | Tremfya inj 100 mg/mL57894-0640-11Listed by the FDA as Tremfyaguselkumab100 mg/mLinjectionJanssen Biotech, Inc. | 26,490.20 (Schedule G, line 19, page 8 of the filing PDF) | 6 |
| 20 | Genvoya tab61958190101Listed by the FDA as Genvoyaelvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide150 mg; 150 mg; 200 mg; 10 mgtabletGilead Sciences, Inc. | 25,826.59 (Schedule G, line 20, page 8 of the filing PDF) | 10 |
| 21 | Shingrix 50 mcg/0.5 mL SUSR58160082311Listed by the FDA as Shingrixzoster vaccine recombinant, adjuvantedkitGlaxoSmithKline Biologicals SA | 22,255.41 (Schedule G, line 21, page 8 of the filing PDF) | 134 |
| 22 | Humalog KwikPen SOPN2879959, 2879759 | 20,985.38 (Schedule G, line 22, page 8 of the filing PDF) | 30 |
| 23 | Paxlovid standard dose 300/100 mg T00069-5045-30, 00069-5321-30 | 20,688.72 (Schedule G, line 23, page 8 of the filing PDF) | 21 |
| 24 | Symtuza tablets59676080030Listed by the FDA as Symtuzadarunavir, cobicistat, emtricitabine, and tenofovir alafenamide800 mg; 150 mg; 200 mg; 10 mgtablet, film coatedJanssen Products LP | 20,426.83 (Schedule G, line 24, page 8 of the filing PDF) | 6 |
| 25 | Freestyle Libre 2 Sensor MISC57599080000 | 19,095.20 (Schedule G, line 25, page 8 of the filing PDF) | 100 |
| 26 | Accu-Chek Guide test STRP65702071110, 65702071210 | 17,185.84 (Schedule G, line 26, page 8 of the filing PDF) | 389 |
| 27 | Trelegy Ellipta 100-62.5-25 AEPB173088710 | 16,154.66 (Schedule G, line 27, page 8 of the filing PDF) | 17 |
| 28 | Apretude ER inj susp49702026423Listed by the FDA as ApretudecabotegravirkitViiV Healthcare Company | 15,794.70 (Schedule G, line 28, page 8 of the filing PDF) | fewer than 6 (the count is not shown) |
| 29 | Victoza 18 mg/3 mL SOPN169406012, 169406013 | 13,926.86 (Schedule G, line 29, page 8 of the filing PDF) | 18 |
| 30 | Linzess 145 mcg caps456120130 | 13,466.47 (Schedule G, line 30, page 8 of the filing PDF) | 10 |
| 31 | Albuterol Sulfate HFA 108 AERS66993001968, 68180096301 | 12,008.38 (Schedule G, line 31, page 8 of the filing PDF) | 357 |
| 32 | Medroxyprogesterone Acetat 150 susp66993037025Listed by the FDA as Medroxyprogesterone Acetate150 mg/mLinjection, suspensionPrasco Laboratories | 11,739.41 (Schedule G, line 32, page 8 of the filing PDF) | 289 |
| 33 | Biktarvy tablets61958-2501-01Listed by the FDA as Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate50 mg; 200 mg; 25 mgtabletGilead Sciences, Inc. | 11,324.90 (Schedule G, line 33, page 8 of the filing PDF) | fewer than 6 (the count is not shown) |
| 34 | Toujeo Solostar 300 units/mL SOPN24586903 | 10,898.55 (Schedule G, line 34, page 8 of the filing PDF) | 12 |
| 35 | Symbicort 160-4.5 mcg/ACT aero186037020 | 10,897.99 (Schedule G, line 35, page 8 of the filing PDF) | 29 |
| 36 | Atorvastatin Calcium tabs60505258008, 60505258009 | 10,856.33 (Schedule G, line 36, page 8 of the filing PDF) | 777 |
| 37 | Humulin KwikPen SUPN2880359 | 10,027.37 (Schedule G, line 37, page 8 of the filing PDF) | 18 |
| 38 | Tivicay 50 mg tablets49702022813Listed by the FDA as Tivicaydolutegravir sodium50 mgtablet, film coatedViiV Healthcare Company | 9,865.71 (Schedule G, line 38, page 8 of the filing PDF) | 9 |
| 39 | Rybelsus 14 mg tabs169431430 | 9,126.35 (Schedule G, line 39, page 8 of the filing PDF) | 6 |
| 40 | Buprenorphine HCl-Naloxon 12-3 film378876893 | 8,878.37 (Schedule G, line 40, page 8 of the filing PDF) | 13 |
| 41 | Ubrelvy 50 mg tabs23649810 | 8,792.47 (Schedule G, line 41, page 8 of the filing PDF) | 9 |
| 42 | Dexcom G7 Sensor MISC8627007701 | 8,755.41 (Schedule G, line 42, page 8 of the filing PDF) | 72 |
| 43 | Juluca tab 50-25 mg49702-0242-13Listed by the FDA as Julucadolutegravir sodium and rilpivirine hydrochloride50 mg; 25 mgtablet, film coatedViiV Healthcare Company | 7,478.37 (Schedule G, line 43, page 8 of the filing PDF) | fewer than 6 (the count is not shown) |
| 44 | Arnuity Ellipta T AEPB173087410 | 7,181.55 (Schedule G, line 44, page 8 of the filing PDF) | 18 |
| 45 | Budesonide/FORM00310737020Listed by the FDA as Budesonide and Formoterol Fumarate Dihydrate160 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP | 6,951.19 (Schedule G, line 45, page 8 of the filing PDF) | 56 |
| 46 | Novolog Flexpen 100 units/mL SOPN169633910 | 6,656.14 (Schedule G, line 46, page 8 of the filing PDF) | 23 |
| 47 | Belbuca buccal film59385002760Listed by the FDA as Belbucabuprenorphine hydrochloride900 mcgfilm, solubleBioDelivery Sciences International Inc | 6,556.67 (Schedule G, line 47, page 8 of the filing PDF) | 21 |
| 48 | Myrbetriq 50 mg TB24469260230 | 6,147.28 (Schedule G, line 48, page 8 of the filing PDF) | 6 |
| 49 | Tetracycline HCl 500 mg caps23155076701, 60219152301, 62135026601 | 5,961.90 (Schedule G, line 49, page 8 of the filing PDF) | 49 |
| 50 | Janumet tabs6057761 | 5,494.84 (Schedule G, line 50, page 8 of the filing PDF) | 7 |
| 51 | Breo Ellipta AEPB173088210 | 5,455.98 (Schedule G, line 51, page 8 of the filing PDF) | 14 |
| 52 | Entresto tab00078-0777-20, 00078-0777-67 | 5,424.49 (Schedule G, line 52, page 8 of the filing PDF) | 14 |
| 53 | Insulin Lispro SOPN2822259 | 5,384.84 (Schedule G, line 53, page 8 of the filing PDF) | 55 |
| 54 | Descovy tab61958-2002-01Listed by the FDA as Descovyemtricitabine and tenofovir alafenamide200 mg; 25 mgtabletGilead Sciences, Inc. | 5,099.62 (Schedule G, line 54, page 8 of the filing PDF) | fewer than 6 (the count is not shown) |
No row matches. | |||
| Total Prescription Drugs individually under $5,000 | 631,129.92 (Schedule G, row for amounts under $5,000, page 8 of the filing PDF) | 34,314 (Schedule G, claims on the row for amounts under $5,000, page 8 of the filing PDF) | |
| Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement | 3,195,260.14 (Schedule G, printed total, page 8 of the filing PDF) | 39,738 (Schedule G, printed claims total, page 8 of the filing PDF) | |
The rows at the foot of the table are always shown. The sum above does not include them.
What “fewer than 6” means. A count of 1 to 5 is not shown on this site or in its data files. Methods, section 9, says how.
Amounts and counts are the filer’s own, in US dollars. They are written here with commas between thousands, and an amount filed with one decimal place is written with two. No value is changed: the filing and the download keep each figure as typed.
Drug names are the filer’s own words. Filers type them in many ways, so this page writes them one way: capitals, spaces, unit names such as mg and mL, a zero before a decimal point, and commas in long numbers. No word is changed, spelled out or left out, and shorthand stays as the filer typed it. The filing and the download keep each name as typed, and a search here reads both.
“Listed by the FDA as” is not part of the filing. It is the name, ingredient, strength, form and labeler that the U.S. Food and Drug Administration’s National Drug Code Directory lists for the row’s code, as downloaded on 11 November 2026. 18 of the 54 rows have one. A row has none when its code is not filed as one 11-digit code or the directory has never listed it. Where the directory has since dropped a code, the name is kept as it was last listed, and the line says so. The directory’s capitals, strengths and unit names are written one way on this page. How a code is matched
Source
- Filing PDF
- Open Schedule G on the State of Rhode Island's website
- SHA-256
- eeeeb9fac3107ae365949d2061132412bc18f6fbd9d5fd3f7bcabc7895e88104
- Retrieved
- 11 November 2026
- Pages used
- 8 of 10